CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, CYP2E1 carries out the omega hydroxylation of fatty acids, increasing lipotoxicity and inflammation [155], which represent major pathophysiological mechanisms in NAFLD progression [156].